Although previously thought to target mostly ion channel proteins rather than signalling pathways [109], NEDD4L (also known as NEDD4-2) has been linked to NOTCH1 down regulation in breast cancer cell lines, and high NEDD4L expression is associated with longer breast cancer relapse-free periods [109]. Here, NOTCH1 is linked to breast cancer.